<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00277030</url>
  </required_header>
  <id_info>
    <org_study_id>NEOUC022005</org_study_id>
    <nct_id>NCT00277030</nct_id>
  </id_info>
  <brief_title>Two Strategies of RDS Treatment in Newborns With Birth Weight &gt; 1500 Grams</brief_title>
  <official_title>Comparative Trial of Two Strategies of RDS Treatment in Newborns With Birth Weight &gt; 1500 Grams</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pontificia Universidad Catolica de Chile</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sociedad Chilena de Pediatría</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Pontificia Universidad Catolica de Chile</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare two different treatment strategies for RDS in preterm
      infants &gt; 1500 grams and evaluate whether a selective surfactant administration would reduce
      the need of intubation, mechanical ventilation and surfactant use.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Respiratory Distress Syndrome (RDS) is a frequent respiratory problem of preterm infants and
      an important cause of morbidity and mortality.

      The management of this disease usually includes intubation, surfactant administration and
      mechanical ventilation in infants less than 1500 grams. However, in patients over this
      weight, the treatment has not been standardized and depends on the clinical progression of
      oxygen requirements.

      Hypothesis:

      - Early CPAP and selective surfactant administration is an effective treatment for RDS in
      infants &gt;1500 g. This could decrease or avoid intubation and surfactant administration.

      Comparison(s):

      Early surfactant administration, when the FiO2 ≥ 0.4. compared to selective surfactant
      administration when the arterial to alveolar oxygen tension ratio (a/APO2) is ≤ 0.21.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2006</start_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The need of intubation and surfactant administration.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mechanical ventilation and CPAP duration.</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen therapy.</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BPD incidence.</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay.</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Enteral feeding tolerance.</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Air leak.</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NEC, gastric perforation.</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death.</measure>
  </secondary_outcome>
  <enrollment>110</enrollment>
  <condition>Respiratory Distress Syndrome</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Surfactant</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nasal CPAP</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Birth Weight &gt; 1500 g.

          -  First day of life.

          -  Clinical and radiological signs of RDS.

          -  Oxygen requirement over 30% to reach an oxygen saturation of 88%.

          -  Parent's consent approved.

        Exclusion Criteria:

          -  Neonatal asphyxia, 5 minute Apgar &lt; 3 or cord pH &lt;7.0.

          -  Cardiac or respiratory malformation.

          -  Chromosomal disease.

          -  Significative pneumothorax.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Day</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Soledad Urzua, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pontificia Universidad Católica</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alvaro Gonzalez, MD</last_name>
    <role>Study Director</role>
    <affiliation>Pontificia Universidad Católica</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Soledad Urzúa, MD</last_name>
    <phone>56-2-3543348</phone>
    <email>soleurzua@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alvaro J Gonzalez, MD</last_name>
    <phone>56-2-3543349</phone>
    <email>alvgonza@med.puc.cl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Servicio de Neonatología, Hospital San José</name>
      <address>
        <city>Santiago</city>
        <state>Región Metropolitana</state>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>German Muhlhausen, MD</last_name>
      <phone>56-2-3832600</phone>
      <phone_ext>2731</phone_ext>
      <email>mygfam@mi.cl</email>
    </contact>
    <investigator>
      <last_name>German Muhlhausen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Servicio de Neonatología, Hospital Sótero del Rio</name>
      <address>
        <city>Santiago</city>
        <state>Región Metropolitana</state>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Mena, MD</last_name>
      <phone>56-2-3536000</phone>
      <phone_ext>6535</phone_ext>
      <email>pmena@uec.uchile.cl</email>
    </contact>
    <investigator>
      <last_name>Patricia Mena, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Unidad de Neonatología, Hospital Clínico Pontificia Universidad Católica</name>
      <address>
        <city>Santiago</city>
        <state>Región Metropolitana</state>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Soledad Urzúa, MD</last_name>
      <phone>56-2-3543348</phone>
      <email>soleurzua@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Alvaro J Gonzalez, MD</last_name>
      <phone>56-2-3543349</phone>
      <email>alvgonza@med.puc.cl</email>
    </contact_backup>
    <investigator>
      <last_name>Soledad Urzúa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <reference>
    <citation>Gregory GA, Kitterman JA, Phibbs RH, Tooley WH, Hamilton WK. Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure. N Engl J Med. 1971 Jun 17;284(24):1333-40.</citation>
    <PMID>4930602</PMID>
  </reference>
  <reference>
    <citation>Saunders RA, Milner AD, Hopkin IE. The effects of continuous positive airway pressure on lung mechanics and lung volumes in the neonate. Biol Neonate. 1976;29(3-4):178-86.</citation>
    <PMID>782570</PMID>
  </reference>
  <reference>
    <citation>Shaffer TH, Koen PA, Moskowitz GD, Ferguson JD, Delivoria-Papadopoulos M. Positive end expiratory pressure: effects on lung mechanics of premature lambs. Biol Neonate. 1978;34(1-2):1-10.</citation>
    <PMID>359057</PMID>
  </reference>
  <reference>
    <citation>Lindner W, Vossbeck S, Hummler H, Pohlandt F. Delivery room management of extremely low birth weight infants: spontaneous breathing or intubation? Pediatrics. 1999 May;103(5 Pt 1):961-7.</citation>
    <PMID>10224173</PMID>
  </reference>
  <reference>
    <citation>Fujiwara T, Maeta H, Chida S, Morita T, Watabe Y, Abe T. Artificial surfactant therapy in hyaline-membrane disease. Lancet. 1980 Jan 12;1(8159):55-9.</citation>
    <PMID>6101413</PMID>
  </reference>
  <reference>
    <citation>Verder H, Albertsen P, Ebbesen F, Greisen G, Robertson B, Bertelsen A, Agertoft L, Djernes B, Nathan E, Reinholdt J. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics. 1999 Feb;103(2):E24.</citation>
    <PMID>9925870</PMID>
  </reference>
  <reference>
    <citation>Avery ME, Tooley WH, Keller JB, Hurd SS, Bryan MH, Cotton RB, Epstein MF, Fitzhardinge PM, Hansen CB, Hansen TN, et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics. 1987 Jan;79(1):26-30.</citation>
    <PMID>3797169</PMID>
  </reference>
  <reference>
    <citation>Gerard P, Fox WW, Outerbridge EW, Beaudry PH. Early versus late introduction of continuous negative pressure in the management of the idiopathic respiratory distress syndrome. J Pediatr. 1975 Oct;87(4):591-5.</citation>
    <PMID>1099184</PMID>
  </reference>
  <reference>
    <citation>Krouskop RW, Brown EG, Sweet AY. The early use of continuous positive airway pressure in the treatment of idiopathic respiratory distress syndrome. J Pediatr. 1975 Aug;87(2):263-7.</citation>
    <PMID>1097619</PMID>
  </reference>
  <reference>
    <citation>Hegyi T, Hiatt IM. The effect of continuous positive airway pressure on the course of respiratory distress syndrome: the benefits on early initiation. Crit Care Med. 1981 Jan;9(1):38-41.</citation>
    <PMID>6780266</PMID>
  </reference>
  <reference>
    <citation>Kamper J, Wulff K, Larsen C, Lindequist S. Early treatment with nasal continuous positive airway pressure in very low-birth-weight infants. Acta Paediatr. 1993 Feb;82(2):193-7.</citation>
    <PMID>8477167</PMID>
  </reference>
  <reference>
    <citation>Lundstrøm KE. Initial treatment of preterm infants--continuous positive airway pressure or ventilation? Eur J Pediatr. 1996 Aug;155 Suppl 2:S25-9. Review.</citation>
    <PMID>8839743</PMID>
  </reference>
  <reference>
    <citation>Finer NN, Carlo WA, Duara S, Fanaroff AA, Donovan EF, Wright LL, Kandefer S, Poole WK; National Institute of Child Health and Human Development Neonatal Research Network. Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial. Pediatrics. 2004 Sep;114(3):651-7.</citation>
    <PMID>15342835</PMID>
  </reference>
  <reference>
    <citation>Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundstrøm K, Jacobsen T. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. N Engl J Med. 1994 Oct 20;331(16):1051-5.</citation>
    <PMID>8090164</PMID>
  </reference>
  <reference>
    <citation>Escobedo MB, Gunkel JH, Kennedy KA, Shattuck KE, Sánchez PJ, Seidner S, Hensley G, Cochran CK, Moya F, Morris B, Denson S, Stribley R, Naqvi M, Lasky RE; Texas Neonatal Research Group. Early surfactant for neonates with mild to moderate respiratory distress syndrome: a multicenter, randomized trial. J Pediatr. 2004 Jun;144(6):804-8.</citation>
    <PMID>15192630</PMID>
  </reference>
  <reference>
    <citation>Bernstein G, Mannino FL, Heldt GP, Callahan JD, Bull DH, Sola A, Ariagno RL, Hoffman GL, Frantz ID 3rd, Troche BI, Roberts JL, Dela Cruz TV, Costa E. Randomized multicenter trial comparing synchronized and conventional intermittent mandatory ventilation in neonates. J Pediatr. 1996 Apr;128(4):453-63.</citation>
    <PMID>8618177</PMID>
  </reference>
  <reference>
    <citation>Early versus delayed neonatal administration of a synthetic surfactant--the judgment of OSIRIS. The OSIRIS Collaborative Group (open study of infants at high risk of or with respiratory insufficiency--the role of surfactant. Lancet. 1992 Dec 5;340(8832):1363-9.</citation>
    <PMID>1360087</PMID>
  </reference>
  <reference>
    <citation>Stevens TP, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev. 2004;(3):CD003063. Review. Update in: Cochrane Database Syst Rev. 2007;(4):CD003063.</citation>
    <PMID>15266470</PMID>
  </reference>
  <reference>
    <citation>Yost CC, Soll RF. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2000;(2):CD001456. Review. Update in: Cochrane Database Syst Rev. 2012;11:CD001456.</citation>
    <PMID>10796266</PMID>
  </reference>
  <verification_date>December 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 5, 2006</study_first_submitted>
  <study_first_submitted_qc>January 11, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2006</study_first_posted>
  <last_update_submitted>August 22, 2006</last_update_submitted>
  <last_update_submitted_qc>August 22, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 24, 2006</last_update_posted>
  <keyword>Respiratory Distress Syndrome</keyword>
  <keyword>Surfactant</keyword>
  <keyword>Nasal CPAP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Birth Weight</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Surfactants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

